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Article
Wnt regulates amino acid transporter Slc7a5 and
so constrains the integrated stress response in
mouse embryos
Nadège Poncet1,† , Pamela A Halley1 , Christopher Lipina2 , Marek Gierlinski3 , Alwyn Dady1 ,
Gail A Singer1 , Melanie Febrer4,‡, Yun-Bo Shi5 , Terry P Yamaguchi6 , Peter M Taylor2 &
Kate G Storey1,*
Abstract
Amino acids are essential for cellular metabolism, and it is impor-
tant to understand how nutrient supply is coordinated with chang-
ing energy requirements during embryogenesis. Here, we show
that the amino acid transporter Slc7a5/Lat1 is highly expressed in
tissues undergoing morphogenesis and that Slc7a5-null mouse
embryos have profound neural and limb bud outgrowth defects.
Slc7a5-null neural tissue exhibited aberrant mTORC1 activity and
cell proliferation; transcriptomics, protein phosphorylation and
apoptosis analyses further indicated induction of the integrated
stress response as a potential cause of observed defects. The
pattern of stress response gene expression induced in Slc7a5-null
embryos was also detected at low level in wild-type embryos and
identified stress vulnerability specifically in tissues undergoing
morphogenesis. The Slc7a5-null phenotype is reminiscent of Wnt
pathway mutants, and we show that Wnt/b-catenin loss inhibits
Slc7a5 expression and induces this stress response. Wnt signalling
therefore normally supports the metabolic demands of morpho-
genesis and constrains cellular stress. Moreover, operation in the
embryo of the integrated stress response, which is triggered by
pathogen-mediated as well as metabolic stress, may provide a
mechanistic explanation for a range of developmental defects.
Keywords amino acid transport; integrated stress response; mouse embryo
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Introduction
Embryonic development involves the patterned proliferation of
emerging cell populations, with some tissues expanding more
rapidly than others to generate new structures, including limb buds
and regions of the developing nervous system. Such expansion is
driven by the localised activity of key signalling pathways, including
fibroblast growth factor and Wnt, e.g. [1–3], and there is growing
evidence that links such signalling to the regulation of metabolic
gene expression [4,5]. Morphogenesis of the embryo also depends
on cell movement and shape changes, and all these cellular
processes have high-metabolic requirements that rely on efficient
uptake of nutrients including amino acids. Indeed, amino acid
supply is essential for survival of pre-implantation mouse embryos
[6,7] and both under and over maternal nutrition can retard
intrauterine growth and increase the risk of morphogenesis failures,
including neural tube defects (reviewed in ref. [8]). Amino acids are
provided to cells via membrane-localised transporters, which specia-
lise in the import of specific types of amino acid. However, rela-
tively little is known about the expression pattern, requirement and
regulation of such transporters during embryogenesis.
The system L1 amino acid transporter isoforms Slc7a5 and
Slc7a8 (aka Lat1 and Lat2, respectively) are the primary (although
usually not exclusive) conduits for delivery of large neutral amino
acids (LNAAs) to many mammalian cell and tissue types. These
include the essential amino acids leucine, isoleucine, phenylalanine,
tryptophan, valine and methionine. Slc7a5 and Slc7a8 are Na+-inde-
pendent amino acid antiporters, typically taking up essential LNAA
in exchange for glutamine [9] or histidine [10]. They are also able to
transport phenylalanine/tyrosine derivatives such as thyroid
hormones T3 and T4 [11] as well as the neurotransmitter precursor
L-DOPA [12]. Both Slc7a5 and Slc7a8 genes encode members of the
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heteromeric amino acid transporter family of proteins which require
a regulatory glycoprotein subunit (in this case 4F2hc/CD98/Slc3a2)
to function correctly [13,14]. Slc7a5-mediated influx of essential
LNAA in particular is recognised to promote net protein synthesis,
cell growth and proliferation, reviewed in [15], by processes includ-
ing activation of the mTORC1 signalling pathway [16,17]. Accord-
ingly, Slc7a5 is over-expressed in many cancers [18,19] and
induction of Slc7a5 is associated with periods of rapid cell growth
and expansion during sustained activation of T lymphocytes [20]. It
also plays an important role in maintenance of critical amino acids
in the brain [10].
Slc7a5 is clearly implicated in various processes essential for
embryonic development such as protein synthesis, cell growth and
proliferation, and we have discovered that Slc7a5-null mice are
embryonic lethal [16]. Early embryos up to and including the blas-
tocyst stage are able to take up LNAA effectively by system B0,+
Na+-coupled transport [21]. Slc7a5 therefore appears to be a good
candidate gene for investigating the role and regulation of nutrient
and hormone uptake during subsequent embryogenesis and to eluci-
date how gene regulatory mechanisms influence such environmen-
tal factors.
Here, we show that Slc7a5 expression is patterned in the mouse
embryo and that Slc7a5-null embryos exhibit profound neural and
limb defects. We characterise this phenotype using key tissue and
cell type-specific markers and interrogate the Slc7a5-null cell state.
We detect modest effects on cell proliferation and mTORC1 activity
in mutant embryos and uncover an early induction of the integrated
stress response (ISR) [22,23]. The ISR is initially adaptive and acts
to restore cell homeostasis, but ultimately leads to apoptosis, which
is increased in Slc7a5-null embryos. Moreover, we show that Wnt
signalling is required for Slc7a5 expression and so prevents ISR
induction, supports the elevated metabolic demands of tissue
morphogenesis and protects against developmental defects.
Results
Slc7a5 is expressed in specific regions of the developing embryo
The spatial and temporal expression pattern of the LNAA trans-
porter Slc7a5 was assessed by mRNA in situ hybridisation in whole
mouse embryos from early primitive streak stages (Fig 1); probe
specificity was assessed in Slc7a5-null embryos, where no signal
was detected (Appendix Fig S1). Slc7a5 mRNA was broadly detected
in epiblast, primitive streak and emerging mesendoderm in the
embryo at E7.0, as well as in extra-embryonic epiblast and meso-
derm [24] (Fig 1A, a1, a2, a20). At E8.5 (Fig 1B, b1–b6), Slc7a5 was
expressed in the open anterior (Fig 1B, b1, b2), and posterior neural
plate, including preneural tube and the caudal lateral epiblast
(Fig 1B, b5, b6), and dorsally in closed neural tube (which includes
presumptive neural crest) and in somites (Fig 1B, b3, b4). At E9.5,
Slc7a5 transcripts continued in all these domains, with high levels
in forebrain and optic vesicle as well as in the otic vesicle and first
brachial arch (Fig 1C, D, c10–c1″), forming cranial ganglia (Fig 1D),
dorsal hindbrain and spinal cord (Fig 1c2–c5) and in the progress
zone of emerging limb buds (Fig 1E). At E10.5 Slc7a5 transcripts
continued to be detected along the rostro-caudal extent of the devel-
oping nervous system at varying levels (Fig EV1), including high
expression in optic and otic vesicles, cranial ganglia (Fig EV1A, a10–
a20), branchial arches (Fig EV1A, a2) and differentiating somites,
neural crest derivatives and mesonephric duct (Fig EV1A, a3). Tran-
scripts were detected more extensively in the limb bud (Fig EV1B,
b1–b2). Notably, Slc7a5 mRNA was most strongly expressed in
dorsal spinal cord (Fig EV1a3, a30) and the forming neural tube aris-
ing from the tailbud (Fig EV1C, c1–c5). Slc7a5 is thus transcribed
highly in neural and other tissues that undergo morphogenetic
movements and/or proliferative expansion in the developing
embryo.
Slc7a5-null embryos exhibit morphological neural tube and
limb defects
To determine the requirement for Slc7a5 during embryogenesis, null
embryos were generated by inter-crossing heterozygote Slc7a5+/
mice (see Materials and Methods). An abnormal phenotype was first
apparent at E9.5 (Fig 2A–H0). Mutant embryos appeared smaller
than littermates and exhibited failure of zippering up along the fore-
and midbrain and closure of the neural tube at site 2 (forebrain/
midbrain boundary) (Fig 2B, F, F0) as well as a delay of posterior
neuropore closure (Fig 2C, E0), while closure at site 1 (at the hind-
brain/cervical spinal cord boundary) is completed [25]. In addition,
Slc7a5-null embryos lacked optic vesicles and had small otic vesicles
(Fig 2D, H, H0) and limb buds (Fig 2B and F). In a subset of Slc7a5-
null embryos, the forebrain formed but failed to expand (Fig EV2).
This is similar to the “flat-top” phenotype observed in mTORC1
mutants or rapamycin (mTORC1 complex inhibitor)-treated
embryos [26,27]. These overt morphological defects in neurulation
and limb bud outgrowth correlate well with the regions in which
Slc7a5 is highly expressed.
Tissue expansion, neurogenesis and neural crest defects in
Slc7a5-null embryos
Marker gene analysis of E9.5 embryos was undertaken next to eluci-
date these developmental defects. Fibroblast growth factor (Fgf) 8
locally regulates expansion of key embryonic tissues, including in
the developing brain and limb [28,29] and is co-expressed in the
rostral forebrain with FoxG1/BF1 [30]. These genes were both
detected in normal (although reduced) domains in the forebrain in
Slc7a5-null embryos (Figs 2I, K, and EV3A, B, D, E) and Fgf8 was
similarly present, but in reduced domains at the midbrain–hindbrain
boundary and the apical ectodermal ridge which signals to the
underlying proliferative progress zone of the limb bud (Fig 2I, J, i1,
j1, K, L, k1, l1). As Fgf8 and FoxG1 are correctly localised, these data
suggest that Slc7a5 loss does not disrupt overall tissue patterning,
but attenuates expansion of cell populations in the developing brain
and limb, which can compromise morphogenetic cell movements,
such as those underlying neural tube closure [31].
To assess whether neuronal differentiation is affected in Slc7a5-
null embryos, we analysed expression of the neural progenitor
marker Neurog2 [32] and the neuronal marker Delta1 [33]. Defective
neural tube closure at fore- and midbrain levels made expression
patterns difficult to compare with littermate controls, but reduced
Neurog2 expression in the brain and spinal cord were evident
(Fig EV3B–F, G–i2), and analysis in the closed neural tube of the
spinal cord revealed the lack of dorsally located Delta1 expressing
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cells [34,35] in null embryos (Fig EV3g3, i3, h1, i4). Further, analy-
sis of tubulin-bIII (Tuj-1) expression, which identifies neurons and
their extending axons [36], revealed striking failure of axonal
outgrowth in the brain and along the length of the neural tube in
Slc7a5-null embryos (Fig 2M–n1). This was particularly evident in
neural crest-derived cranial and spinal ganglia (Fig 2M, m1, N, n1),
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and this was consistent with reduced Neurog2 expression in these
cell populations (Fig 2O–o4, P–p4) [37].
To dissect further the requirement for Slc7a5 in neural crest,
Sox10 expression was used to identify migrating neural crest and its
derivatives [38,39]. Sox10 expression domains were less extensive
in Slc7a5-null embryos (Fig 3A and B) including cranial as well as
spinal ganglia (Fig 3a4, b4). We next assessed pre-migratory neural
crest cells within the dorsal neural tube itself. These cells express
Pax3, which acts early in the neural crest gene regulatory network
[40,41]. The domain of Pax3 expression in the dorsal neural tube
was reduced in Slc7a5-null embryos (Fig 3C and D, quantified in
3G), suggesting a role for Slc7a5 in the self-renewal of the pre-migra-
tory pool of neural crest precursors [42]. In contrast, expression of
FoxA2 in the ventral neural tube and notochord appeared unaltered
in Slc7a5-null embryos (Fig 3E and F). These data identify specific
defects in the expansion and differentiation of cells in the dorsal
neural tube in Slc7a5-null embryos. Overall, this marker gene analy-
sis indicates a requirement for Slc7a5 in cell populations undergoing
energetic activities, differentiation, extensive movement, cell shape
change or expansive growth during the morphogenesis phase of
embryonic development.
Slc7a5-null embryos exhibit a mild cell proliferation defect and
aberrant mTORC1 activity
To assess whether cells in Slc7a5-null embryos exhibit reduced
proliferation, we next used an antibody against phosphorylated
histone 3 (phospho-H3) to identify mitotic cells (Fig 4A–D). We first
quantified phospho-H3-positive cells in the spinal cord (at the level
of the forelimb) (Fig 4A and B). This revealed no difference in
mitotic index in the absence of Slc7a5 (Fig 4E). The latter region
was selected for analysis because mutant embryos complete neuru-
lation in this region and exhibited minimal morphological defects
and facilitating comparison with wild-type embryos. We therefore
next assessed the mitotic index in the forebrain, where Slc7a5-null
embryos exhibit profound defects, failing to form optic vesicles and
undergo neurulation. Surprisingly, although the neuroepithelium
appears depleted in Slc7a5-null forebrain, the mitotic index was only
just significantly reduced (Fig 4C, D and F). This modest effect in
the forebrain and the lack of effect in the spinal cord suggest that
reduced cell proliferation is unlikely to be the major explanation for
the defects observed in Slc7a5-null neural tube.
The resemblance of the forebrain phenotype in a subset of
Slc7a5-null embryos to the flat-top phenotype resulting from
reduced mTORC1 activity [26,27], the requirement for Slc7a5 for full
activation of mTORC1 in some other cellular contexts [16,17,20]
along with the well-established role of this pathway in integrating
nutrient and mitogen signals [15], raised the possibility that altered
mTORC1 signalling might underlie the Slc7a5-null phenotype. We
took two approaches to assess this possibility. By immunocyto-
chemistry, the phosphorylated form of ribosomal protein S6 (S6 is a
P70S6 kinase substrate and often used as surrogate reporter for
mTORC1 signalling [43]) was detected (using antibodies recognising
phospho-Ser235/236 (Fig 4G and H) or phospho-Ser240/244
(Appendix Fig S2C and D). Strikingly, phospho-S6 levels in neural
tube sections varied markedly from cell to cell in Slc7a5-null, but
not in wild-type embryos (Fig 4G and H, quantified in 4I), indicating
a more heterogeneous pattern of mTORC1 activity in the loss-of-
function condition. In contrast, Western blot for phospho-Thr389 of
P70S6 kinase (a key substrate of mTORC1) did not show a dif-
ference between wild-type and Slc7a5-null conditions in E9.5
embryo lysates (Fig 4J). This may reflect aberrant rather than
absent mTORC1 signalling activity in a subset of cells, which may
be beneath detection in whole embryo lysates. Together, these find-
ings suggest that reduced mTORC1 activity is just beginning to be
detectable at the time when profound morphological defects are
manifest in Slc7a5-null embryos.
Transcriptome analysis implicates the integrated stress
response and discounts a role for thyroid hormone in the
Slc7a5-null phenotype
As we detected only a small effect on cell proliferation in Slc7a5-null
embryos, we next took an unbiased approach to uncover the earliest
effects of Slc7a5 loss. This additionally allowed us to determine
whether Slc7a5 transport of tyrosine derivatives (including thyroid
hormones (TH) T3 and T4) as well as LNAAs might underlie the
observed developmental defects. To this end, we carried out RNA-
seq on wild-type and Slc7a5-null embryos at E8.5, just prior to
appearance of phenotypic defects and compared resulting transcrip-
tomes (see Materials and Methods). Significant changes
(FDR < 0.05) in the expression of only seven gene transcripts, one
pseudogene and two lincRNAs were found in Slc7a5-null embryos
(Table 1, Datasets EV1 and EV2). These changes were confirmed by
◀ Figure 1. Slc7a5 mRNA expression pattern in the early mouse embryo.A E7.0 whole embryo and transverse section (TSs) (dashed lines) through (a1) extra-embryonic tissue showing expression in a ring of extra-embryonic ectoderm (ee)
and extra-embryonic mesoderm (em) and absence of transcripts in the allantois (al); (a2) revealing expression in epiblast (ep) and in mesendoderm (me) emerging
from the primitive streak (ps), dashed box (a20) defines higher magnification region shown in a2.
B E8.5 whole embryo dorsal view and TSs (dashed lines) showing expression in: (b1–b3) the open anterior neural plate (future fore-, mid- and hindbrain) including (b3)
neural crest (nc) emerging from hindbrain; (b4) in the dorsal neural tube (prospective neural crest) and dorsal somites (s); (b5) in closing preneural tube neural (pnt)
and epithelising somites; (b6) in caudal lateral epiblast (cle) adjacent to the node (n) at the anterior tip of the primitive streak, but not in presomitic mesoderm (psm).
White arrows indicate open anterior and posterior neural plate.
C E9.5 whole embryo side view and TSs (white dashed lines) showing expression in: (c1) forebrain (fb) and hindbrain, including optic vesicles (opv), (c10) seen at high
magnification (and indicated by box grey dashed line) and otic vesicles (ov) (c1″) seen at high magnification (box grey dashed line); (c2) high expression in dorsal
hindbrain (hb) and (c3) spinal cord (sc) and dermamyotome (dm) of the differentiating somite; (c5) throughout open posterior neural plate.
D High magnification of E9.5 whole embryo showing expression in first branchial arch (ba) and forming cranial ganglia, which are just becoming apparent, (V), (VII),
(VIII) (IX) and (X). OV, otic vesicle.
E Expression in mesenchyme cells underlying the apical ectodermal ridge (aer) in the progress zone (pz) and in the zone of polarising activity (zpa) of the forelimb (fl).
Data information: Images representative of n ≥ 4 embryos for each stage. Scale bars 200 µm, except sections 100 µm.
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RT–qPCR for 6 genes: Slc7a5, Klhdc4 and Spire2 were downregu-
lated and Chac1, Trib3 and Pck2 were upregulated (Fig 4K).
These data confirm efficient knockout of Slc7a5, while Klhdc4
and Spire2 reduction are unlikely to be functionally significant,
given the remaining level of expression in Slc7a5-null embryos and
the existence of other isoforms (see Table 1 and Fig 4K). Analysis in
Slc7a5-null embryos further confirmed that transcription and protein
levels of Slc7a5 partner Slc3a2/CD98 are not reduced in this context
(Appendix Fig S3). In contrast, two of the confirmed significantly
upregulated genes Chac1 (cation transport regulator homolog-1) and
Trib3 (tribbles pseudokinase-3, aka TRB3, NIPK or SKIP3) are impli-
cated in endoplasmic reticulum (ER) stress and the unfolded protein
response (UPR) [45–47]. Chac1 is distantly related to Botch, a nega-
tive regulator of Notch signalling [48]; however, we found no
evidence for change in Notch signalling in Slc7a5-null embryos
(Appendix Fig S4). Transcription of the third confirmed upregulated
gene, Pck2 (phosphoenolpyruvate carboxykinase-2), is activated by
amino acid deficiency and ER stress and also plays a role in gluco-
neogenesis, a stress-related metabolic pathway [45,49]. In addition,
a further two upregulated genes just below significance, Aldh1l2
(aldehyde dehydrogenase 1 family, member L2) and Asns (as-
paragine synthetase) (Dataset EV1), are also well-known cellular
stress-activated genes [50,51]. Multiple stress stimuli, including
amino acid deprivation and ER stress, converge on induction of the
integrated stress response (ISR) [22,23]. This is an adaptive
response which acts to restore cellular homeostasis by decreasing
global protein synthesis while promoting mRNA translation for
selected proteins. These include the key mediator of the ISR, activat-
ing transcription factor (ATF) 4, and this leads to upregulation of
ATF4 transcriptional targets, many of which alter cell metabolism
so as to mitigate cellular stress [52]. These findings therefore
suggest that promotion of the ISR is an early consequence of Slc7a5
loss in developing embryos.
We further assessed whether altered transport of phenylalanine/
tyrosine derivatives might contribute to the mutant phenotype.
Indeed, TH signalling has been implicated in expansion of the cere-
bral cortex at later developmental stages [53]. No changes in genes
associated with L-DOPA were found in the RNA-seq data, and while
TH target gene Dio3 was slightly reduced in an analysis in which
one outlier data set was removed (Dataset EV2), this was not con-
firmed in Slc7a5-null embryos assessed by qPCR (Appendix Fig
S5A). Furthermore, Dio3 and thyroid hormone receptors THRb and
THRa were barely detectable until after E10.5 in wild-type embryos
(Appendix Fig S5B, D, E, F). These data strongly suggest that the
dopamine and thyroid hormone systems do not operate during the
period when the Slc7a5 phenotype is first manifest. Overall, these
findings identify loss of Slc7a5 function as a transporter of LNAA as
the likely underlying cause of these early neural developmental and
limb defects.
Slc7a5-null embryos exhibit localised integrated stress response
To investigate the activation of the ISR in Slc7a5-null embryos,
qPCR was carried out for key genes that mediate this response in
stage E9.5 embryos (when the phenotype is now apparent). This
included Chac1 and Trib3 and also ATF4 as well as C/EBP homo-
logue protein (CHOP). CHOP is an effector of a pro-apoptotic
response which is triggered if cellular stress persists [52,54]. CHOP
acts together with ATF4 to promote transcription of Chac1 and Trib3
which, along with other stress-induced pathways, promote apopto-
sis [46,47]. Chac1, Trib3 and CHOP were significantly upregulated
in Slc7a5-null embryos (Fig 4L). ATF4 transcription showed a simi-
lar trend, but was not significantly increased, perhaps reflecting that
ATF4 response to stress is primarily at the level of mRNA transla-
tion [55]. In addition, Trib3 may act as a feedback inhibitor of ATF4
transcription [56].
To localise this stress response within the developing Slc7a5-null
embryo, the expression patterns of Chac1 and Trib3 were next
assessed by mRNA in situ hybridisation. Strikingly, transcripts were
found at high levels in Slc7a5-null embryos in regions that normally
express Slc7a5 but were not detected in E9.5 wild-type embryos
processed in parallel (Fig 5A–H). This was particularly apparent in
the brain, branchial arches and otic vesicles as well as dorsal neural
tube and limb buds of mutant embryos (Fig 5B, b1–b6, D, F, f1–f6,
H). To substantiate further Trib3 and Chac1 as markers of cellular
stress in the embryo, we additionally analysed their expression
following brief exposure of whole E8.5 wild-type embryos to ER
stress inducers, tunicamycin and thapsigargin, which also provoke
the ISR [57]. This revealed rapid and localised induction of both
Trib3 and Chac1, particularly in the neural tube (Appendix Fig S6).
Interestingly, Chac1 and Trib3 transcripts could also eventually
be detected at low level in wild-type embryos in a similar pattern to
that in Slc7a5-null, if the mRNA detection reaction was continued
for > 3 days (Fig 5I–M and see Appendix Fig S7). These findings
strongly suggest that loss of Slc7a5 promotes localised ISR in the
embryo as it undergoes morphogenesis and, given detection of
◀ Figure 2. Slc7a5-null embryos exhibit overt neural tube closure and limb bud outgrowth defects, reduced Fgf8 expression domains and aberrant neuronal andneural crest differentiation.
A–H Live wild-type littermate and Slc7a5-null embryos imaged shortly after dissection. (A–D) Wild-type and (E–H) Slc7a5-null E9.75 embryos from lateral (A, D, E, H),
frontal (B, F) or dorsal (C, G) views; (e1–h1) higher magnification images of the Slc7a5-null embryo. White arrowheads indicate the smaller limb bud (compare B
and F), open/reduced forebrain (compare D and H), open neural tube at posterior (compare C and E, e1) and anterior (compare B and F, f1) regions. Black
arrowheads indicate kinked neural tube (compare C and G, g1) and apparently missing optic and smaller otic vesicles (ov) (compare D and h1).
I–P mRNA in situ hybridisation and immunofluorescence in E9.5 or E10.5 wild-type and Slc7a5-null embryos for key marker genes. (I–L) Fgf8 mRNA transcripts were
detected in wild-type (I–j1) and in Slc7a5-null (K–l1) E10.5 embryos (n = 4 each) (white arrowheads indicate limb buds in K and the isthmus in L) with (j1, l1)
sections through isthmus at midbrain/hindbrain border and (i1, k1) lateral views of forelimb buds. (M, N) Wholemount tubulin-b-III (Tuj1) immunofluorescence
performed on (M, m1) wild-type and (N, n1) Slc7a5-null E9.5–E10.5 embryos (n = 5 each condition). Dorsal root ganglia (DRG) and sympathetic chain ganglia (SCG)
are indicated with open arrowheads together with cranial ganglia IX, X and XI. Images in (m1, n1) show higher magnification of the cranial ganglia V, VII/VIII (open
arrowheads). (O, P) Neurog2 expression in wild-type (O–o4) and Slc7a5-null embryos (P–p4) (n = 5 and n = 6 each), showing reduced expression in forebrain (o2,
p2), cranial ganglia (o1, o3, p1, p3, arrowheads) and spinal cord at level of forelimb (o4, p4, arrowheads indicate position of neural crest).
Data information: Scale bars 200 µm, except sections 100 µm.
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low-level transcription of these ISR-linked genes in these cell popu-
lations in wild-type embryos, further suggest that this initially adap-
tive mechanism normally operates in dynamic cell populations to
ensure cell homeostasis.
Slc7a5 loss triggers the integrated stress response via
phosphorylation of GCN2 and eIF2a and induces apoptosis
The canonical ISR pathway is activated via phosphorylation, and so,
inactivation of the translation initiation factor eIF2a by one or more
of four eIF2a kinases and amino acid deprivation triggers activation
of the kinase GCN2 [23]. Increased phosphorylation of GCN2 and
eIF2a was detected in E9.5 Slc7a5-null whole embryo lysates
(Fig 6A and B). Moreover, we were able to detect localised induc-
tion of p-eIF2a in E9.5 Slc7a5-null embryos, extensively in the
forebrain and locally in key tissues including the otic vesicle
(Fig 6C–f2). These findings indicate that loss of Slc7a5 triggers acti-
vation of the kinase GCN2 and further substantiate the induction of
ISR in Slc7a5-null embryos.
Induction of ATF4 targets Trib3, Chac1 and CHOP is indicative of
a progressed cell stress response [46,47], which if unresolved ulti-
mately leads to apoptosis [52,58]. Here, we confirmed raised levels
of Trib3 protein in Slc7a5-null embryos (Fig 6G), which correlate
with the localised high-level transcription of this gene (Fig 5F–H).
We therefore next assessed cell death in Slc7a5-null embryos using
a TUNEL assay. This revealed widespread apoptotic figures in the
developing brain of E9.5 Slc7a5-null embryos (Fig 6H–L); however,
this varied between samples and the profound and varied morpho-
logical defects in this region in null embryos made it difficult to
quantify with respect to wild type (Fig 6I). Analysis of TUNEL-posi-
tive cells in sections of the dorsal spinal cord and caudal hindbrain
also revealed variability between embryos (with an F-test
P = 0.0003), but could be quantified (Fig 6J and K, quantified in L).
These findings indicate that most Slc7a5-null embryos exhibit
increased cell death. This is consistent with local triggering of apop-
tosis as stress levels rise on a cell-by-cell basis.
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Figure 3. Slc7a5-null embryos exhibit altered expression of neural crest
genes.
A, B Sox10 in situ hybridisation in (A) wild-type and (B) Slc7a5-null E9.5
embryos (n = 4 each) with TSs of (a1, b1) the hindbrain at level of
trigeminal ganglion V, (a2, b2) otic vesicles and the neural tube at more
posterior levels (a3, a4, b3, b4). Scale bars 200 µm, except sections a1–b4,
100 µm. Closed white arrowheads in (a3, a4) indicate neural crest, and
open white arrowheads indicate depleted neural crest in (b3) and
position where neural crest should be in (b4).
C–F Immunofluorescence on TS caudal spinal cord of E9.5 wild-type
littermates and Slc7a5-null embryos; Pax3 and FoxA2 were used as
indicators for dorso-ventral organisation in (C, E) wild type, n = 2 (for
FoxA2) and n = 4 (For Pax3) and (D, F) Slc7a5-null, n = 3 (for FoxA2) and
n = 3 for Pax3) neural tube. Arrowheads indicate border of Pax3
expression domain. Scale bars 50 µm.
G Percentage of Pax3-expressing cells was determined by counting these
cells and all DAPI-labelled nuclei in the neural tube and comparison
made between wild type (four embryos, six sections each) and Slc7a5-
null (three embryos, six sections each), each dot represents the average
for one embryo, unpaired t-test, *P = 0.018 (see original source data).
Error bars indicate SEM.
Source data are available online for this figure.
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Slc7a5 expression depends on Wnt/b-catenin signalling, and loss
of this pathway induces the stress response gene Trib3
Finally, we noticed that the Slc7a5-null phenotype is similar to that
observed in Wnt pathway mutants, which also exhibit defects in the
dorsal neural tube, involving neurogenesis and neural crest as well
as in limb development [1,2,59]. Moreover, there is a good corre-
spondence between Wnt signalling and Slc7a5 expression in caudal
epiblast/primitive streak and dorsal neural tube as well as in the
limb bud [60] (Fig 1b3, b6, c3, E). Dorsal neural tube defects are
dependent on canonical, b-catenin-mediated, Wnt signalling [61].
This suggests that loss of such signalling might contribute to the
Slc7a5-null phenotype and/or that Slc7a5 transcription is normally
promoted downstream of b-catenin signalling.
To address whether canonical Wnt signalling is compromised in
Slc7a5-null embryos, we assessed expression of the b-catenin tran-
scriptional target Axin2. This revealed robust expression of Axin2 in
both littermate (Fig 7A, a1–a3) and Slc7a5-null embryos (Fig 7B,
b1–b3) indicating that loss of Slc7a5 does not impact canonical Wnt
signalling. We next investigated whether Slc7a5 is a potential canon-
ical Wnt signalling target, first by analysing its promoter region for
binding sites of relevant transcription factors using the eukaryotic
promoter database and the MatInspector program [62]. These analy-
ses identified two putative LEF1 and TCF7L2 sites upstream of the
mouse Slc7a5 transcription start site (TSS) and multiple potential
MYC binding sites flanking the TSS (Fig EV4 and see Dataset EV3),
supporting the possibility that Slc7a5 is a target of this pathway in
the developing embryo.
◀ Figure 4. Slc7a5-null neural tube exhibits slightly reduced cell proliferation and aberrant mTORC1 activity, and qPCR validation of significantly changedgenes in Slc7a5-null embryos.
A–D Proliferation was assessed in the spinal cord (forelimb level) (A, B) using a phospho-Histone 3 (phospho-H3) antibody (green) to identify mitotic cells and
DAPI (blue) to label nuclei; cells were counted in 3 wild-type (18 sections) and 3 Slc7a5-null embryos (18 sections) and mitotic index calculated; (C, D)
proliferation was also assessed in the forebrain in three wild-type embryos (17 sections) and three Slc7a5-null embryos (16 sections). White dashed lines
indicate midline.
E, F Comparison of mitotic index in wild-type and Slc7a5-null (E) spinal cord, P = 0.872, and (F) forebrain *P = 0.049, each dot represents the average for one embryo,
unpaired t-test (see original source data).
G, H mTORC1 activity in the spinal cord (hindlimb level) was assessed by immunofluorescence using an antibody against the phospho-ribosomal protein S6 (phospho-
S6 Ser 235/236).
I Labelling intensity was measured and plotted relative to DAPI intensity; six wild-type embryos (18 sections) and five Slc7a5-null embryos (19 sections). Each dot
represents the average for one embryo, (*P = 0.0457) unpaired t-test with Welch correction (see original source data).
J Western blot of individual E9.5 wild-type (n = 3) nd Slc7a5-null (n = 4) embryo lysates immunoblotted using an antibody against phospho-S6K (Thr389) and total
P70S6K for loading control. Band intensities were measured with FIJI, and an unpaired t-test was performed for statistical analysis (see original source data).
K, L (K) Validation by qPCR of the targets identified by RNA-seq; qPCR was performed on individual E8.5 embryos of each genotype (wild type n = 5, heterozygous n = 9
and Slc7a5-null n = 7). (L) qPCR was performed on individual E9.5 embryos (wild type n = 5, heterozygous n = 3 and Slc7a5-null n = 4) using primers specific for
genes associated with the integrated stress response. A one-way ANOVA test with a Tukey post-test was performed.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001, for actual P-values, see original source data file. Error bars indicate SEM. All scale bars 50 µm.
Source data are available online for this figure.
Table 1. Seven genes significantly changed in E8.5 Slc7a5-null embryos.
Gene_ID Gene logFC P-value FDR Description
ENSMUSG00000110631 Gm42047 11.1 0 0 lincRNA
ENSMUSG00000040010 Slc7a5 4.95 <1016 <1016 Solute carrier family 7 (cationic amino acid transporter, y+ system),
member 5
ENSMUSG00000074052 BC048644 4.35 4.6 × 1012 4.0 × 108 cDNA sequence BC048644
ENSMUSG00000112478 AC153370.2 3.59 <1016 2.8 × 1014 lincRNA
ENSMUSG00000040263 Klhdc4 1.14 <1016 <1016 Kelch domain containing 4
ENSMUSG00000010154 Spire2 0.948 3.1 × 1011 2.4 × 107 Spire homolog 2 (Drosophila)
ENSMUSG00000032815 Fanca 0.387 7.2 × 106 0.038 Fanconi anaemia, complementation group A
ENSMUSG00000040618 Pck2 0.594 7.3 × 1010 4.8 × 106 Phosphoenolpyruvate carboxykinase 2 (mitochondrial)
ENSMUSG00000032715 Trib3 1.851 6.9 × 108 0.00040 Tribbles pseudokinase 3
ENSMUSG00000027313 Chac1 3.431 1.2 × 1013 1.2 × 109 ChaC, cation transport regulator 1
RNA-seq data based on 5 wild-type littermates and 5 Slc7a5-null E8.5 embryos identified 7 genes showing significant change in expression (and see
Appendix Table S1). Slc7a5 was downregulated with a log2 fold change of 4.948 (equivalent to > 99.9% reduction in mRNA expression (Fig 4H)). Klhdc4 (Kelch
domain containing 4) and Spire2 (spire-type actin nucleation factor 2) genes were both downregulated to a much lesser extent with log2 fold changes of ~ 1,
confirmed by reductions in mRNA expression to ~ 50% of wild-type level. Klhdc4 is a highly abundant transcript, and Spire2 is functionally redundant with Spire1
(Pfender et al, 2011; Fig 4H), so the observed changes in their expression levels seem unlikely to be functionally significant (and may be associated with their
close proximity to the Slc7a5 locus on chromosome 8). Upregulated genes, Chac1, Trib3 and Pck2, are all metabolic stress-related genes (see text). Correlation
between samples was high (r > 0.98), and additional analysis without one WT outlier had a small effect on the significant gene list, adding several further genes
associated with metabolic stress (Appendix Table S2).
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To test this regulatory relationship, embryo trunk explants were
exposed to the Wnt secretion inhibitor Wnt-c59, which inhibits Wnt
palmitoylation [63]. After 16 h, Axin2 expression was unchanged in
DMSO vehicle-only condition, but repressed by Wnt-c59 (Fig 7C, c1,
D, d1). Similarly, Slc7a5 was attenuated in the presence of Wnt-c59
(Fig 7E, e1, F, f1), placing Slc7a5 transcription downstream of Wnt
signalling. We then assessed Slc7a5 expression in mouse embryos
lacking functional b-catenin. As deletion of b-catenin results in early
embryonic lethality [64], we used a conditional approach, crossing
mice harbouring floxed alleles of b-catenin (Ctnnb1tm2Kem) [65] with
a mouse line expressing Cre recombinase under the control of the T
(Brachyury) promoter (T-Cre) [66] and mutant embryos generated
are referred to here as T-Cre;Ctnnb1flLOF/D. In these mice, the Cre
recombinase is expressed in axial progenitors and their descendants
which give rise to the posterior spinal cord and paraxial mesoderm
[66–68]. This cross-generates embryos in which b-catenin is lost
from the developing body axis beginning in the caudal epiblast and
primitive streak from ~ E7.5 and by E9.5 also in axial progenitor
descendants. At E9.5, T-Cre;Ctnnb1flLOF/D embryos exhibit a trun-
cated phenotype in which development of paraxial mesoderm is
attenuated and remaining axial tissue forms neuroepithelium [68].
Importantly, this caudal-most neural tube lacked Slc7a5 transcripts
compared to littermate controls (Fig 7G, g1–g3 and H, h1–h3), indi-
cating that Scl7a5 transcription in the neural tube relies on b-
catenin.
As loss of b-catenin leads to failure to form paraxial mesoderm,
it is formally possible that the absence of other signals provided by
this tissue underlies loss of Slc7a5 expression in the adjacent neural
tube. If this were the case, we would expect Slc7a5 to be lost in
embryos in which the b-catenin downstream transcription factors
Sp5 and Sp8 are mutated, as these embryos also fail to form paraxial
mesoderm [69]. However, as in littermate controls (Fig EV5A, a1–
a3), Sp5/Sp8 compound mutant embryos continue to express Slc7a5
right to the caudal end (Fig EV5B, b1–b3). This finding indicates
that Slc7a5 expression in the neural tube does not depend on signals
from the newly formed paraxial mesoderm and further that Slc7a5 is
regulated by b-catenin downstream transcription factors other than
Sp5 and Sp8. Indeed, available ChIP-seq data show that while Sp5
and Sp8 bind to early mesodermal genes, they do not target Slc7a5
in differentiating mouse ESCs [70].
As Slc7a5 loss induces the ISR, we next assessed whether b-
catenin deletion also triggers this stress response. Analysis of early
(E7.5–8.25) T-Cre;Ctnnb1flLOF/D embryos revealed mosaic induction
of ISR gene Trib3 in the earliest T-Cre domains, including posterior
epiblast and primitive streak, but not in littermate controls (Fig 7I–
j2). Later at E9.5, T-Cre;Ctnnb1flLOF/D embryos, but not littermate
controls, exhibited patches of Trib3-expressing cells in the region of
the body axis truncation (Fig 7K–m3). This included groups of cells
where somitic mesoderm should have formed (see open arrows
Fig 7m2) and in gut endoderm (a known site of T-Cre expression
[66]) (Fig 7l3) as well as cells in the lumen of the spinal cord
(Fig 7l2); this pattern of later Trib3 induction may reflect mosaic
Cre recombination and time required for the consequences of Slc7a5
loss to be manifest.
Together, these findings show that Wnt and b-catenin signalling
are required for Slc7a5 transcription in the forming neural tube and
implicate canonical Wnt signalling in constraint of the integrated
stress response.
Discussion
By elucidating the expression pattern, requirement and regulation of
the amino acid transporter Slc7a5, this study uncovers a mechanism
by which cell metabolism is regulated by developmental signalling
in the mammalian embryo. Elevated expression of Slc7a5 in tissues
undergoing morphogenesis revealed that amino acid transport is
patterned in the embryo. The phenotype of Slc7a5-null embryos
indicated a requirement for increased amino acid transport for
neural tube closure, neurogenesis and neural crest development as
well as limb bud outgrowth. Aberrant mTORC1 activity and neural
progenitor proliferation may underlie aspects of this phenotype.
However, pre-phenotypic transcriptomics and subsequent detection
of ATF4 transcriptional targets as well as phosphorylated GCN2 and
eIF2a indicated Slc7a5 loss rapidly triggers the ISR. Moreover, this
correlated with elevated apoptosis, which is the likely cause of the
observed developmental defects. The detection of low levels of ISR
gene transcripts in wild-type embryos further suggested that cells
participating in morphogenesis are particularly vulnerable to cell
stress. Finally, the requirement for Wnt signalling for Slc7a5 expres-
sion identified a new regulatory mechanism, in which Wnt
promotes morphogenesis at least in part by inducing expression of
this essential amino acid importer, thereby locally supporting meta-
bolic demand and forestalling cell stress during this critical develop-
mental period.
These data show that the effects of Slc7a 5 loss in the mouse
embryo involve rapid induction of the ISR and are most likely due
to intracellular LNAA deficiency activating the eIF2a kinase, GCN2.
Indeed, ISR genes including Trib3, Aldh1l2 and Pck2 are among the
top transcripts induced by leucine starvation in HEK293 cells [71];
moreover, Slc7a5 loss in human cancer cell lines has been shown to
induce this stress response [19,72,73]; we detect aberrant activity of
the amino acid sensor mTORC1; and transcriptomic analysis did not
reveal changes in other potentially linked pathways, dopamine and
thyroid hormone systems. While we detect elevated phosphoryla-
tion of GCN2 and eIf2a indicative of ISR induction in Slc7a5-null
◀ Figure 5. Slc7a5-null embryos exhibit localised integrated stress response.A–L mRNA in situ hybridisation was performed at E9.5 to detect Chac1 in (A–a6) wild-type and (B–b6) Slc7a5-null littermate embryos (n = 3 for each condition); Chac1
expression at E10 in emerging limb buds assessed in (C) wild-type and (D) Slc7a5-null littermate embryos (n = 2 for each condition); Trib3 mRNA detected in (E-e6)
wild-type and (F–f6) Slc7a5-null littermate embryos (n = 3 for each condition) and in emerging limb buds at E10.5 assessed in (G) wild-type and (H) Slc7a5-null
littermate embryos (n = 2 for each condition). Chac1 and Trib3 transcripts were also detected in wild-type E9.5 embryos after > 3 days in situ hybridisation reaction
(n = 3 and n = 6, respectively). Lateral view (I and K), optic vesicles (white arrowheads), branchial arches (ba) and otic vesicles (ov). Dorsal view (J and L), neural
tube (nt) and limb buds (white arrowheads). Scale bars 200 µm for whole embryo images and 100 µm for sections.
M Schematic indicating regions (purple) in which high levels of Slc7a5 (see Fig 1C–E) and ISR genes Trib3 and Chac1 are detected in wild-type embryos.
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embryos, progression of the ISR was indicated by induction of the
pro-apoptosis gene CHOP, which together with ATF4 directly
promotes Trib3 [47,74] and Chac1 [46]. The correlation between
Trib3 and Chac1 induction and increased apoptosis demonstrated
that these genes are good reporters for ISR activity in the embryo
and allowed identification of tissues particularly sensitive to cellular
stresses. This included developing neural tissue, which we addition-
ally confirmed in response to exogenous ER stressors in E8.5
embryos, but also limb buds which form later in E9.5 embryos and
exhibit high-level Chac1 and Trib3 in Slc7a5-null embryos.
Together, these data strongly suggest that rapid induction of apopto-
sis underlies the developmental defects generated by Slc7a5 loss and
identify ISR induction as a potential upstream driver of this process.
Interestingly, transcriptional targets for further cell death pathways
identified in the context of ER stress, such as that mediated by IRE1
[75], were not detected in our E8.5 RNA-seq data, but studies at
later stages are required to exclude such activity. To confirm ISR
causality, rescue experiments are also required: although we note
that inhibiting this stress response will not compensate for the
underlying amino acid deficiency and so may attenuate but will not
resolve this phenotype.
The appearance of a phenotype in Slc7a5-null embryos only at
E9.5 indicates that this gene is not critically required for some
morphogenesis events that take place during early embryogenesis.
This includes gastrulation and axial elongation and may reflect func-
tional redundancy with the related gene, Slc7a8/Lat2 (although this
is not fully reciprocal; the Slc7a8 knockout mouse has only a minor
phenotype [76]). Nonetheless, loss of amino acid import by both
these transporters (a condition generated when their regulatory
subunit, CD98/Slc3a2, is mutated [77–79]) results in earlier lethality
from E7.5 [14]. Death of Slc7a5-null embryos at E10.5 may reflect
onset of dependence on chorion–allantoic circulation and Slc7a5
expression in extra-embryonic tissue and later placenta [80,81].
Importantly, the detection of low-level Trib3 and Chac1 tran-
scripts in Slc7a5 domains of expression in wild-type embryos
suggested that adaptive ISR is normally ongoing in energetic cell
populations in the mammalian embryo. This is consistent with a
homeostatic role for elf2a phosphorylation in buffering protein
synthesis in normal unstressed cells [82]. Slc7a5 is one of a number
of stress-mitigating genes involved in amino acid transport reported
to be upregulated by ER stress in cell lines [83,84]. Indeed, the Slc7a5
gene contains a cis-acting ER stress response element (ERSE) that
binds ATFs [83,85]. These findings suggest that Slc7a5 expression is
normally regulated by positive feedback once the ISR is activated.
Such action may contribute to elevated Slc7a5 expression during
energetic activities and serve to ensure timely morphogenesis.
◀ Figure 6. Cell death is increased in Slc7a5-null embryos, and exogenous ER stress induction in wild-type embryos upregulates Chac1 and Trib3.A, B Western blot of individual E9.5 wild-type (n = 4) and Slc7a5-null (n = 4) embryo lysates immunoblotted using an antibody against phospho-GCN2 (Thr899) and
total GCN2 (loading control), ***P = 0.0001; or against phospho-eIF2a (Ser51) and total eIFa (loading control), *P = 0.0482, band intensities measured with FIJI and
analysed with unpaired t-test (see original source data).
C–F Phosphorylated eIFa was assessed by immunofluorescence in E9.5 embryos in the forebrain, wild type (C, c1) (n = 2 embryos, 0/14 sections) and Slc7a5-null (D, d1)
(n = 2 embryos 16/16 sections), and in hindbrain/anterior spinal cord, wild type (E–e2) (n = 4 embryos, 0/62 sections) and Slc7a5-null (F–f2) (n = 4 embryos, 54/54
sections) including in the otic vesicle (compare e2, f2). Scale bars in (C–e1, D–f1) 100 µm and in (e2 and f2) 25 µm. Arrowheads indicate ventral midline.
G An increase in Trib3 protein was detected by Western blot in Slc7a5-null embryos; each lane represents an E9.5 embryo lysate (wild type n = 3, Slc7a5-null, n = 4)
with a-tubulin loading control, unpaired t-test *P = 0.0153 (see original source data).
H–L TUNEL assay to detect apoptotic cells in wild type (n = 3 embryos, 32 sections) or Slc7a5-null (n = 5 embryos, 47 sections); (H, I) transverse sections through the
head at level of the forebrain and (J, K) the spinal cord, (H–K) scale bars 50 µm, arrowheads indicate ventral midline. (L) Quantification of TUNEL-positive cells
within spinal cord sections was performed as stated in Materials and Methods. Each dot represents the average apoptosis cell count for a single embryo, Welch’s
correction unpaired t-test, P = 0.250, F-test to compare variances, P = 0.0003 (see original source data).
Data information: All error bars indicate SEM.
Source data are available online for this figure.
▸Figure 7. Wnt b-catenin signalling is unaffected in Slc7a5-null embryos, but is required for Slc7a5 transcription and b-catenin loss induces ISR gene Trib3.A, B (A, a1) Wnt b-catenin target Axin2 strongly expressed in littermate, (a2, a3) in TS, and (B, b1) in Scl7a5-null embryos (b2, b3) in TS (n = 2 littermates, n = 6/6
Slc7a5-null embryos).
C, D (C, d1) Axin2 transcripts in embryo trunk explant exposed to DMSO (C, c1, n = 12/12) were reduced in Wnt-c59-exposed explants (D, d1, n = 14/14). Images in (c1,
d1) show TS through explants (data from three independent embryo explant experiments).
E, F Slc7a5 transcripts in embryo trunk explant exposed to DMSO (E, e1, n = 9/10) or Wnt-c59 (F, f1, n = 15/15). Images in (e1, f1) show TS through explants (data from
3 independent embryo explant experiments).
G, H Slc7a5 expression in control T-Cre;Ctnnb1flLOF/D heterozygous littermate embryo (G, g1) and in TS (g2, g3), and in T-Cre;Ctnnb1flLOF/D mutant embryo where Slc7a5
transcripts are absent in posterior neural tube (the region of T-Cre recombination, indicated with white arrowhead in H) and shown in TS in (h2, h3) (n = 0/6
littermate and n = 6/6 mutant embryos).
I, J Trib3 is lacking in T-Cre;Ctnnb1flLOF/D heterozygous control embryos at E7.75 (I), caudal region dissected from the same embryo (white dashed box in I) (i1) and
viewed in TS (i2); Trib3 detected in homozygous T-Cre;Ctnnb1flLOF/D embryo (J), in caudal region dissected from the same embryo (white dashed box in J) (j1) and
shown in TS in caudal epiblast and remnant primitive streak (ps) (j2) (n = 3/3 T-Cre;Ctnnb1flLOF/D embryos and 14 littermate controls). Trib3 was also detected in
the more rostral forming neural tube at this early stage (seen in J) and so in cells not directly experiencing b-catenin loss; this may reflect the failure to form
paraxial mesoderm, which provides signals that promote and support neurogenesis.
K–M At E9.5, Trib3 was not detected in T-Cre;Ctnnb1flLOF/D heterozygous littermate embryos (K, k1) and in TS (k2, k3), but was detected in homozygous T-Cre;Ctnnb1flLOF/D
mutant embryos (L-m3) in patches of cells in neural tube (nt) (L-l2), gut (g) (l3) and somites (s) (m2, arrowheads) (n = 9/9 T-Cre;Ctnnb1flLOF/D embryos and 12
littermate controls).
Data information: White dashed lines indicate position of sections. Scale bars, in (A, a1, B, b1, G, g1, H, h1) = 200 µm, in (C–F) = 100 µm, all sections 50 µm.
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Although Slc7a5 may be upregulated by adaptive ISR in the
embryo, this seemed unlikely to be its only regulator as mice lacking
this stress pathway do not phenocopy the Slc7a5 deletion [82]. The
similarities between the phenotypes of Slc7a5-null and Wnt pathway
mutants are striking. Not only do they affect many of the same cell
populations, with Wnt mutants also exhibiting defects in
neurulation, neural crest [59] and neurogenesis [61] as well as limb
bud outgrowth [1,2], but they also share phenotypic detail. For
example, in the dorsal neural tube, loss of Slc7a5 or Wnt reduces
neuronal differentiation [61] and both Wnt3a/Wnt1 double-mutant
[59] and Slc7a5-null embryos possess cell populations derived from
the first emerging neural crest, but exhibit reduction of later forming
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dorsal root ganglia, consistent with a failure to expand the Pax3
expressing neural crest progenitor pool [42]. Importantly, such
dorsal neural tube defects have been shown to result specifically
from loss of b-catenin-mediated signalling [61] and also Myc [42]
and we show here that Slc7a5 transcription is lost following inhibi-
tion of Wnt secretion or deletion of b-catenin in the forming neural
tube. Furthermore, the presence of binding sites for known media-
tors of canonical Wnt signalling LEF/TCF and the direct Wnt target
MYC upstream of Slc7a5, along with ChIP-seq data, showing that
b-catenin binds the Slc7a5 promoter in the Xenopus embryo [86]
and ChIP-PCR data demonstrating that MYC directly binds the
Slc7a5 promoter in human cancer cell lines and promotes Slc7a5
transcription [19] strongly support the possibility that Slc7a5 is a
direct Wnt-b-catenin/MYC target in the mouse embryo. This conclu-
sion is reinforced by screens which place Wnt upstream of Slc7a5 in
other cellular contexts and point to conservation of this regulatory
relationship [87,88].
In addition, Wnts have other downstream pathways and these
include promotion of mTORC1 activity in a variety of cell lines,
independently of b-catenin signalling [89–91]. As loss of Slc7a5 and
so local amino acid deficiency lead to aberrant mTORC1 activity,
this suggests a further explanation for the similarity between muta-
tions affecting Wnt ligands [59] and Slc7a5-null embryos. Indeed,
mTORC1 activity is required for normal neurogenesis in the chick
neural tube [92] and for neural crest differentiation and survival
[93]. This also suggests operation of cross-talk between mTORC1
and b-catenin-mediated Wnt pathways, which serves to maintain
proteostasis. Such regulation may in turn be modulated by input
from the adaptive ISR as it promotes expression of stress-mitigating
genes including Slc7a5. Moreover, Wnt promotion of metabolic gene
expression is characteristic of many cancer cell states, for example,
b-catenin-promoted cMyc expression upregulates glycolytic genes in
such contexts [94], supporting the view that multiple Wnt down-
stream pathways orchestrate cellular metabolism. Our finding that
the ISR gene Trib3 is induced in b-catenin mutant embryos further
connects Wnt signalling to the regulation of cellular stress.
Importantly, monitoring in Slc7a5-null embryos for phospho-S6
and also TUNEL-positive cells underlined that the consequences of
stress in tissues are manifest on a cell-by-cell basis and that these
may differ according to the activity of individual cells during
embryogenesis. Moreover, a critical mass of cells may need to be
affected to generate a developmental defect and while adaptive
stress may delay morphogenesis, chronic stress and so transition to
apoptosis may be more likely to occur when multiple stresses are
present. Indeed, the ISR integrates a range of cellular stresses which
activate distinct eIF2a kinases; for example, amino acid deficiency
activates GCN2 and ER stress kinase PERK (protein kinase R (PKR)-
like endoplasmic reticulum kinase), while viral or bacterial infec-
tion activates protein kinase R (PKR) and iron deficiency activates
haem-regulated kinase (HRI) by [23]. It may be that small changes
in, for example, nutrient supply could promote sustained cellular
stress across a cell population in particular genetic backgrounds or
when pathogens abound. Indeed, there are examples of gene–envi-
ronment interactions which account for the sporadic nature of
human diseases, such as Crohn’s [95], neural tube [18,96] and
heart, skeletal and renal defects [97], as well as those induced by
hypoxia [98,99]. Moreover, hypoxia-induced reduction in FGFR1
protein leading to heart defects in mouse embryo has been linked
to induction of p-PERK and the ISR in the context of the unfolded
protein response [100].
These findings make important new links between signalling,
metabolism, cell stress and developmental defects in the mamma-
lian embryo and suggest that Wnt activity normally locally promotes
Slc7a5 to elevate amino acid supply in cells participating in morpho-
genesis. This identification of Wnt signalling as a key regulator of
cell stress in embryonic tissues opens the way to wider investigation
of how metabolic demand and the ISR are regulated in particular
cell populations and how the level, timing and integration of cell
stresses lead to specific developmental defects.
Materials and Methods
Mouse lines and embryo collection
Slc7a5fl/fl mice harbouring two copies of the Slc7a5-targeted allele
(exon 1 of Slc7a5 flanked with two loxP sites) were crossed with a
mouse line ubiquitously expressing Cre recombinase under the Bal1
promoter (Bal1-cre) to obtain a global Slc7a5 knockout mouse line
[16]. Heterozygous Slc7a5+/ C57Bl/6 mice were viable and fertile
and were bred free of Bal1-cre in subsequent generations [16];
however, Slc7a5+/ inter-crosses did not produce any Slc7a5-null
live mice. Here, heterozygous Slc7a5+/ mice were crossed to
generate litters between E8.5 and E11.5. An abnormal phenotype
was not found in E8.5-null embryos (35/128 Slc7a5/ embryos
from 18 litters), but was apparent at E9.5 (35/162 Slc7a5/
embryos from 19 litters) and the oldest live Slc7a5-null embryos
were found at E10.5 (6/28 Slc7a5/ embryos from three litters).
Sex and genotype of embryos were determined by PCR.
To generate embryos lacking b-catenin in axial progenitors,
Ctnnb1tm2Kem mice [65] harbouring two copies of the floxed b-
catenin loss-of-function (LOF) allele (exons 2–6, including the ATG
and domains essential for binding E-cadherin and TCF/LEF flanked
with two loxP sites), referred to as Ctnnb1flLOF/flLOF, were crossed
with a mouse line homozygous for the T-Cre transgene (which
expresses Cre recombinase under the control of the T/Bra promoter
[66]) and heterozygous at the Ctnnb1 locus deleted for exons 2–6
(T-Cretg/tg; Ctnnb1Dex2-6/+). In this cross, both mutant (T-Cretg/+;
CtnnbDex2-6/flLOF) (referred to here as T-Cre;Ctnnb1flLOF/D) and
control littermates (T-Cretg/+; Ctnnb1flLOF/+) (referred to here as
littermate het) are generated at 50% frequency. Sp5/Sp8 compound
mutants were generated as described in [69].
Wild-type CD1 embryos were collected between E7.0 and E9.5.
Embryos were fixed in PFA 4% and processed for in situ hybridisa-
tion or immunofluorescence as described below. Mouse colonies
were breed, mice sacrificed and embryos isolated following Home
Office guidelines (PPL 60/04454 or PPL 60/3455 and/or 60/4118).
Mouse embryo and explant culture and exposure to
small molecules
Live E8.5 CD1 embryos were dissected from the uterus and collected
within yolk sacs in warm (37°C) culture media (F12 + Gluta-
max + FCS 10%). Hanging drop culture method [101] was then
used with DMSO (1:1,000) or ER stress inducers: tunicamycin
(1 lg/ml) and thapsigargin (1 lM). Embryos were cultured for 6 h
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at 37°C in 5% CO2, then dissected, fixed and processed for in situ
hybridisation. E9.5 CD1 mouse embryos were dissected in ice-cold
medium, and explants of the trunk region were made, embedded in
collagen and cultured in OptiMem/10%FBS/1×GlutaMAX/1× B27/
1xPen strep (all from Gibco) in an incubator with 5% CO2 at 37°C,
as described previously [102]. Explants were cultured in either vehi-
cle control DMSO or Wnt-C59 (Tocris, Cat. No. 5148) at 4 lM (1/
2,500) in DMSO for 16 h. Explants consisted of full thickness of the
embryo at the level of the three most recently formed somites (cau-
dal explant) or at the level of the three next rostral somites (rostral
explant) (caudal explants were only compared with other caudal
explants and rostral explants only compared with other rostral
explants). Following fixation in ice-cold 4% PFA, explants were
processed for in situ hybridisation to detect mRNAs or for immuno-
cytochemistry as described above.
In situ hybridisation for mRNA
In situ hybridisation experiments were performed on whole
embryos to detect mRNA for Delta1, Neurog2, FoxG1, Fgf8, Hes5,
Sox10, Slc7a5, Slc3a2, Chac1 and Trib3 following standard proce-
dures. Primers used to clone Slc7a5, Slc3a2, Chac1 and Trib3 can be
found in Appendix Table S1. Subset of embryos subjected to whole-
mount in situ hybridisation was embedded and cryo-sectioned using
standard procedures to localise mRNA at a cellular level.
Immunofluorescence
A standard protocol was used to embed and cryo-section embryos at
20 lm for immunofluorescence. Primary antibodies were used at
indicated concentrations: phospho-H3 (S10), phospho-S6 (S235/
236) and phospho-S6 (S240/244) (1:500—Cell Signaling Technology
#9706, #5364, #2211), phospho-eIf2a (1:500—Cell Signaling Tech-
nology #3398), tubulin-bIII (Tuj1, 1:500—MMS-435P, BioLegend),
Pax3 (1:200—supernatant DSHB) and FoxA2 (1:200—ab108422,
Abcam). Secondary antibodies goat anti-rabbit IgG (H+L) cross-
adsorbed secondary antibody, Alexa Fluor 594 (A-11012, Thermo
Fisher) and donkey anti-mouse IgG (H+L) secondary antibody,
Alexa Fluor 488 conjugate (A-21202, Thermo Fisher) were incu-
bated for 30 min at 1:500 at room temperature. Nuclei were stained
with DAPI.
TUNEL assay
Detection of cells with DNA-strand breaks was performed on
sections of E9.5 wild-type or Slc7a5-null embryos by the TUNEL
labelling method, using an ApopTag kit (Millipore) according to the
manufacturer’s instructions. Images were taken with Leica DMRB
microscope using a ×20 objective. To identify TUNEL-positive cells,
a colour threshold of 100 was set in ImageJ, and all cells above this
threshold were counted in the dorsal 700 lm of the spinal cord. For
quantification, see text, figure legends and original source data.
Microscopy
Whole embryo images (mRNA in situ hybridisation and Tuj-1
immunofluorescence) were taken using a Micropublisher 3.3RT and
Q-Imaging on a Leica MZFLIII dissecting microscope. Representative
sections were imaged using Leica DRB compound microscope. On
sectioned tissues, immunofluorescence was imaged using either a
personal DeltaVision imaging system (20× lens for Figs 3C–F, 4A, B,
G, H and Appendix Fig S2A–D; 10× lens Fig 4C, D (nine images
taken and stitched using ImageJ) or with SP8 Leica confocal micro-
scope ×10 (Fig 6C–f1) ×60 (Fig 6e2, f2). To quantify the varied
pattern of phospho-S6 (Fig 4G, H, I), fluorescence intensity was
measured using ImageJ and normalised relative to the intensity of
DAPI fluorescence in the same area (see original source data).
Figures were assembled using Adobe Photoshop and Illustrator soft-
ware for composite figure construction.
Preparation of RNA-seq samples
E8.5 embryos with 8–10 somites were dissected in cold PBS and
lysed individually with TRIzol reagent. Embryos were stage
matched with respect to somite number, and only male embryos
were used to avoid potential sex-related variations in transcriptome.
Allantois was kept for genotyping and sexing the embryos by PCR
[103]. Total RNA was extracted using the RNeasy mini kit (Qiagen).
Samples were DNase-treated “on-column” using RNase-free DNase
(Qiagen). Quality and quantity of total RNA were measured using a
Qubit fluorometer (Invitrogen). Following quality control, 5 wild-
type and 5 Slc7a5-null male embryos were selected as biological
replicates. Samples started with 300 ng total RNA per embryo to
which spike-ins (ERCC, 2 ll of 1:100 dilution) were added. We used
a TruSeq RNA v2 kit (Illumina RS-122-2001) to prepare the cDNA
library following the manufacturer’s instructions; polyA RNA selec-
tion was performed and fragment and random priming followed by
cDNA synthesis, ligation and ×10 rounds of PCR amplification.
RNA-seq was performed by Illumina HiSeq 2000 with 100 bp paired
ends and “dye-swap” spike-in of all samples. This gave paired-end
reads, length 101 bp, between 28 and 42 million reads per sample.
Computational analysis of RNA-seq data
Reads were aligned to the Ensembl GRCm38 primary assembly
genome (release 90) using STAR ver. 2.5.3a [104] with the following
parameters –genomeLoad NoSharedMemory –outSAMstrandField
intronMotif –outSAMmode Full –outFilterMultimapNmax 2 –outFil-
terMismatchNmax 5 –outFilterType BySJout –outSJfil-
terIntronMaxVsReadN 5000 10000 15000 20000 –readFilesCommand
zcat –outSAMtype BAM SortedByCoordinate –outSAMunmapped
Within –outReadsUnmapped Fastx –quantMode GeneCounts. Read
counts per gene were calculated in the same STAR run. The gene
annotation file (release 90) was downloaded from Ensembl. For dif-
ferential expression, edgeR ver. 3.18.1 [105,106] was applied with its
default normalisation, which resulted in a list of log2 fold changes,
raw P-values and Benjamini–Hochberg-corrected P-values to control
the false discovery rate (FDR) (see Table 1, Appendix Tables S1 and
S2).
Quantitative PCR
RNA from E8.5 or E9.5 embryos (respectively, 200 and 500 ng)
was reverse-transcribed using the qScript cDNA synthesis kit
(Quanta Biosciences). A 1/10 dilution of the cDNA was used to
perform qPCR on a Bio-Rad iCycler with PerfeCTa SYBR Green
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FastMix (Quanta Biosciences). Primer pairs used can be found in
Appendix Table S2. qPCRs for each embryo were run in triplicate,
and the average of these technical replicates was taken to represent
one independent experiment. Comparisons of such data from at least
three embryos (see Figure legends) were made for each condition
and each gene of interest. All data were determined using DDCt
method [107] and shown relative to GAPDH with error bars indicat-
ing SEM. A one-way ANOVA with a Tukey post-test was performed
for statistical analyses (see original source data).
Preparation of whole embryo lysates and Western blotting
To prepare samples for SDS–PAGE electrophoresis, isolated whole
mouse embryos were immediately transferred to a clean microtube
containing ice-cold lysis buffer [50 mM Tris–HCl, pH 7.5, 1% Triton
X-100, 1 mM EGTA, 1 mM EDTA, 150 mM NaCl, 0.27 M sucrose,
50 mM sodium fluoride, 10 mM sodium 2-glycerophosphate, 5 mM
sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM benza-
midine, 1 mM PMSF and 0.1% 2-mercaptoethanol, EDTA-free
protease inhibitor cocktail (Roche) (1 individual embryo per tube)].
Following sonication and vortexing, the resulting homogenate was
centrifuged at 3,000 g for 10 min at 4°C to remove remaining tissue
debris, and the resulting supernatant was used for Western blot
analysis. Each lane was loaded with lysate from one embryo (this
was 20 lg, except for the blot for Slc3a2 in which lanes were loaded
with 25 lg). Loaded lysates were then subjected to SDS–polyacry-
lamide gel electrophoresis and immunoblotted as previously
described [16] using primary antibodies (1:1,000) against (Cell
Signaling, Beverly, MA, USA, phospho-P70S6K (T389) #9205,
P70S6K #2708, phospho-eIF2a (S51) #3398 and eIF2a #9722, TRB3
(Proteintech, Chicago, IL, USA, #13300-1-AP) and a-Tubulin (Sigma,
St Louis, MO, USA, #T6074, used at 1:5000), pGCN2 (T899) (Abcam
ab75386) and GCN2 (Abcam ab134053), Slc3a2 (Santa Cruz #sc-
20018), b-Actin (Cell Signaling Technology cat#4970). Primary anti-
body detection was carried out with (Cell Signaling, Beverly, MA,
USA) secondary antibodies, anti-rabbit IgG-HRP #7074 or anti-
mouse IgG-HRP-linked #7076 at (1:5,000) as appropriate by ECL.
Resulting band intensities were quantified using FIJI software (NIH,
Bethesda, MD), and unpaired t-tests were performed for statistical
analyses. In figures, solid black bars indicate where blots were cut
and dashed lines separate wild-type and Slc7a5-null lanes. See origi-
nal source data for complete blots.
Data availability
RNA-seq data are available in ArrayExpress accession number
E-MTAB-6336, https://www.ebi.ac.uk/arrayexpress/experiments/
E-MTAB-6336/.
Expanded View for this article is available online.
Acknowledgements
We thank members of the Storey Laboratory and colleagues Cheryll Tickle,
Andy Copp, Linda Sinclair and David Ron for critical reading of versions of this
manuscript. We are grateful to Dr Ravi Chalamalasetty for generation and
collection of T-Cre;Ctnnb1flLOF/D and Sp5/Sp8 compound mutant embryos. This
research was supported by a Wellcome Trust project grant to PT (WT094226)
on which KGS was a named collaborator and NP was further supported for a
short period by the ISSF (WT204816/Z/16). YBS is supported by NIH, and TPY
is supported by NIH (project number 1ZIABC010345-18). This study utilised
microscopy resources supported by a Wellcome Trust multi-user equipment
grant for the development of tissue imaging approaches (WT101468). KGS is a
Wellcome Trust Investigator (WT102817AIA).
Author contributions
Conception or design of the work or the acquisition, analysis or interpretation
of data for the work: NP, MG, MF, CL, PAH, GAS, AD, TPY, PMT and KGS; Draft-
ing the work or revising it critically for important intellectual content: NP, MG,
MF, CL, PAH, TPY, PMT and KGS; Final approval of the version to be published:
NP, MG, MF, CL, PAH, GAS, AD, Y-BS, PMT and KGS; Agreement to be account-
able for all aspects of the work in ensuring that questions related to the accu-
racy or integrity of any part of the work are appropriately investigated and
resolved: KGS.
Conflict of interest
The authors declare that they have no conflict of interest.
References
1. Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R (1999)
Wnt3a/ like phenotype and limb deficiency in Lef1(/)Tcf1(/)
mice. Genes Dev 13: 709 – 717
2. Yamaguchi TP, Takada S, Yoshikawa Y, Wu N, McMahon AP (1999) T
(Brachyury) is a direct target of Wnt3a during paraxial mesoderm spec-
ification. Genes Dev 13: 3185 – 3190
3. Crossley PH, Martinez S, Martin GR (1996) Midbrain development
induced by FGF8 in the chick embryo. Nature 380: 66 – 68
4. Oginuma M, Moncuquet P, Xiong F, Karoly E, Chal J, Guevorkian K,
Pourquie O (2017) A gradient of glycolytic activity coordinates FGF and
Wnt signaling during elongation of the body axis in amniote embryos.
Dev Cell 40: 342 – 353 e310
5. Miyazawa H, Aulehla A (2018) Revisiting the role of metabolism during
development. Development 145: dev131110
6. Gardner DK, Lane M (1993) Amino acids and ammonium regulate
mouse embryo development in culture. Biol Reprod 48: 377 – 385
7. Devreker F, Hardy K, Van den Bergh M, Vannin AS, Emiliani S, Englert Y
(2001) Amino acids promote human blastocyst development in vitro.
Hum Reprod 16: 749 – 756
8. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE (2004) Maternal
nutrition and fetal development. J Nutr 134: 2169 – 2172
9. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998)
Expression cloning and characterization of a transporter for large
neutral amino acids activated by the heavy chain of 4F2 antigen
(CD98). J Biol Chem 273: 23629 – 23632
10. Tarlungeanu DC, Deliu E, Dotter CP, Kara M, Janiesch PC, Scalise M,
Galluccio M, Tesulov M, Morelli E, Sonmez FM et al (2016) Impaired
amino acid transport at the blood brain barrier is a cause of autism
spectrum disorder. Cell 167: 1481 – 1494 e1418
11. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Henne-
mann G, Visser TJ (2001) Thyroid hormone transport by the heterodi-
meric human system L amino acid transporter. Endocrinology 142:
4339 – 4348
12. Kageyama T, Nakamura M, Matsuo A, Yamasaki Y, Takakura Y, Hashida
M, Kanai Y, Naito M, Tsuruo T, Minato N et al (2000) The 4F2hc/LAT1
ª 2019 The Authors EMBO reports e48469 | 2019 17 of 20
Nadège Poncet et al EMBO reports
complex transports L-DOPA across the blood-brain barrier. Brain Res
879: 115 – 121
13. Mastroberardino L, Spindler B, Pfeiffer R, Skelly PJ, Loffing J, Shoemaker
CB, Verrey F (1998) Amino-acid transport by heterodimers of 4F2hc/
CD98 and members of a permease family. Nature 395: 288 – 291
14. Sato Y, Heimeier RA, Li C, Deng C, Shi YB (2011) Extracellular domain
of CD98hc is required for early murine development. Cell Biosci 1: 7
15. Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci
122: 3589 – 3594
16. Poncet N, Mitchell FE, Ibrahim AF, McGuire VA, English G, Arthur JS, Shi
YB, Taylor PM (2014) The catalytic subunit of the system L1 amino acid
transporter (slc7a5) facilitates nutrient signalling in mouse skeletal
muscle. PLoS One 9: e89547
17. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B,
Yang H, Hild M, Kung C, Wilson C et al (2009) Bidirectional transport
of amino acids regulates mTOR and autophagy. Cell 136: 521 – 534
18. Wang F, Wu Y, Gu H, Reece EA, Fang S, Gabbay-Benziv R, Aberdeen G,
Yang P (2015) Ask1 gene deletion blocks maternal diabetes-induced
endoplasmic reticulum stress in the developing embryo by disrupting
the unfolded protein response signalosome. Diabetes 64: 973 – 988
19. Yue M, Jiang J, Gao P, Liu H, Qing G (2017) Oncogenic MYC activates a
feedforward regulatory loop promoting essential amino acid metabo-
lism and tumorigenesis. Cell Rep 21: 3819 – 3832
20. Sinclair LV, Rolf J, Emslie E, Shi YB, Taylor PM, Cantrell DA (2013)
Control of amino-acid transport by antigen receptors coordinates the
metabolic reprogramming essential for T cell differentiation. Nat
Immunol 14: 500 – 508
21. Van Winkle LJ, Tesch JK, Shah A, Campione AL (2006) System B0,+
amino acid transport regulates the penetration stage of blastocyst
implantation with possible long-term developmental consequences
through adulthood. Hum Reprod Update 12: 145 – 157
22. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun
C, Popko B, Paules R et al (2003) An integrated stress response regu-
lates amino acid metabolism and resistance to oxidative stress. Mol
Cell 11: 619 – 633
23. Pakos-Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman AM
(2016) The integrated stress response. EMBO Rep 17: 1374 – 1395
24. Pereira PN, Dobreva MP, Graham L, Huylebroeck D, Lawson KA, Zwijsen
AN (2011) Amnion formation in the mouse embryo: the single amnio-
chorionic fold model. BMC Dev Biol 11: 48
25. Copp AJ, Greene ND (2013) Neural tube defects–disorders of neurula-
tion and related embryonic processes. Wiley Interdiscip Rev Dev Biol 2:
213 – 227
26. Hentges K, Thompson K, Peterson A (1999) The flat-top gene is required
for the expansion and regionalization of the telencephalic primordium.
Development 126: 1601 – 1609
27. Hentges K, Sirry B, Gingeras A-C, Sarbassov D, Sonenberg N, Sabatini
DM, Peterson A (2001) FRAP/mTOR is required for proliferation and
patterning during embryonic development in the mouse. Proc Natl
Acad Sci USA 98: 13796 – 13801
28. Okada T, Okumura Y, Motoyama J, Ogawa M (2008) FGF8 signaling
patterns the telencephalic midline by regulating putative key factors of
midline development. Dev Biol 320: 92 – 101
29. Storm EE, Rubenstein JL, Martin GR (2003) Dosage of Fgf8 determines
whether cell survival is positively or negatively regulated in the devel-
oping forebrain. Proc Natl Acad Sci USA 100: 1757 – 1762
30. Shimamura K, Rubenstein JL (1997) Inductive interactions direct early
regionalization of the mouse forebrain. Development 124: 2709 – 2718
31. Nikolopoulou E, Galea GL, Rolo A, Greene ND, Copp AJ (2017) Neural
tube closure: cellular, molecular and biomechanical mechanisms. Devel-
opment 144: 552 – 566
32. Gradwohl G, Fode C, Guillemot F (1996) Restricted expression of a novel
murine atonal-related bHLH protein in undifferentiated neural precur-
sors. Dev Biol 180: 227 – 241
33. Henrique D, Adam J, Myat A, Chitnis A, Lewis J, Ish-Horowicz D (1995)
Expression of a Delta homologue in prospective neurons in the chick.
Nature 375: 787 – 790
34. Scardigli R, Schuurmans C, Gradwohl G, Guillemot F (2001) Crossregu-
lation between Neurogenin2 and pathways specifying neuronal iden-
tity in the spinal cord. Neuron 31: 203 – 217
35. Helms AW, Johnson JE (2003) Specification of dorsal spinal cord
interneurons. Curr Opin Neurobiol 13: 42 – 49
36. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A (1990) The
expression and posttranslational modification of a neuron-specific
beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskele-
ton 17: 118 – 132
37. Dupin E, Coelho-Aguiar JM (2013) Isolation and differentiation proper-
ties of neural crest stem cells. Cytometry A 83: 38 – 47
38. Southard-Smith EM, Kos L, Pavan WJ (1998) Sox10 mutation disrupts
neural crest development in Dom Hirschsprung mouse model. Nat
Genet 18: 60 – 64
39. Kuhlbrodt K, Herbarth B, Sock E, Hermans-Borgmeyer I, Wegner M
(1998) Sox10, a novel transcriptional modulator in glial cells. J Neurosci
18: 237 – 250
40. Sato T, Sasai N, Sasai Y (2005) Neural crest determination by co-acti-
vation of Pax3 and Zic1 genes in Xenopus ectoderm. Development 132:
2355 – 2363
41. Betancur P, Bronner-Fraser M, Sauka-Spengler T (2010) Assembling
neural crest regulatory circuits into a gene regulatory network. Annu
Rev Cell Dev Biol 26: 581 – 603
42. Kerosuo L, Bronner ME (2016) cMyc regulates the size of the premigra-
tory neural crest stem cell pool. Cell Rep 17: 2648 – 2659
43. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR.
Genes Dev 18: 1926 – 1945
44. Pfender S, Kuznetsov V, Pleiser S, Kerkhoff E, Schuh M (2011) Spire-
type actin nucleators cooperate with formin-2 to drive asymmetric
oocyte division. Curr Biol 21: 955 – 960
45. Mendez-Lucas A, Hyrossova P, Novellasdemunt L, Vinals F, Perales JC
(2014) Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) is
a pro-survival, endoplasmic reticulum (ER) stress response gene
involved in tumor cell adaptation to nutrient availability. J Biol Chem
289: 22090 – 22102
46. Mungrue IN, Pagnon J, Kohannim O, Gargalovic PS, Lusis AJ (2009)
CHAC1/MGC4504 is a novel proapoptotic component of the unfolded
protein response, downstream of the ATF4-ATF3-CHOP cascade. J
Immunol 182: 466 – 476
47. Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H (2005) TRB3, a novel
ER stress-inducible gene, is induced via ATF4-CHOP pathway and is
involved in cell death. EMBO J 24: 1243 – 1255
48. Chi Z, Zhang J, Tokunaga A, Harraz MM, Byrne ST, Dolinko A, Xu J,
Blackshaw S, Gaiano N, Dawson TM et al (2012) Botch promotes
neurogenesis by antagonizing Notch. Dev Cell 22: 707 – 720
49. Stark R, Guebre-Egziabher F, Zhao X, Feriod C, Dong J, Alves TC, Ioja S,
Pongratz RL, Bhanot S, Roden M et al (2014) A role for mitochondrial
phosphoenolpyruvate carboxykinase (PEPCK-M) in the regulation of
hepatic gluconeogenesis. J Biol Chem 289: 7257 – 7263
18 of 20 EMBO reports e48469 | 2019 ª 2019 The Authors
EMBO reports Nadège Poncet et al
50. Quiros PM, Prado MA, Zamboni N, D’Amico D, Williams RW, Finley D,
Gygi SP, Auwerx J (2017) Multi-omics analysis identifies ATF4 as a key
regulator of the mitochondrial stress response in mammals. J Cell Biol
216: 2027 – 2045
51. Lomelino CL, Andring JT, McKenna R, Kilberg MS (2017) Asparagine
synthetase: function, structure, and role in disease. J Biol Chem 292:
19952 – 19958
52. Hetz C (2012) The unfolded protein response: controlling cell fate deci-
sions under ER stress and beyond. Nat Rev Mol Cell Biol 13: 89 – 102
53. Stenzel D, Wilsch-Brauninger M, Wong FK, Heuer H, Huttner WB (2014)
Integrin alphavbeta3 and thyroid hormones promote expansion of
progenitors in embryonic neocortex. Development 141: 795 – 806
54. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ (2008) Chop
deletion reduces oxidative stress, improves beta cell function, and
promotes cell survival in multiple mouse models of diabetes. J Clin
Invest 118: 3378 – 3389
55. Dey S, Baird TD, Zhou D, Palam LR, Spandau DF, Wek RC (2010) Both
transcriptional regulation and translational control of ATF4 are central
to the integrated stress response. J Biol Chem 285: 33165 – 33174
56. Jousse C, Deval C, Maurin AC, Parry L, Cherasse Y, Chaveroux C, Lefloch
R, Lenormand P, Bruhat A, Fafournoux P (2007) TRB3 inhibits the tran-
scriptional activation of stress-regulated genes by a negative feedback
on the ATF4 pathway. J Biol Chem 282: 15851 – 15861
57. Oslowski CM, Urano F (2011) Measuring ER stress and the unfolded
protein response using mammalian tissue culture system. Methods
Enzymol 490: 71 – 92
58. Tabas I, Ron D (2011) Integrating the mechanisms of apoptosis induced
by endoplasmic reticulum stress. Nat Cell Biol 13: 184 – 190
59. Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S (1997) Wnt signal-
ling required for expansion of neural crest and CNS progenitors. Nature
389: 966 – 970
60. Ferrer-Vaquer A, Piliszek A, Tian G, Aho RJ, Dufort D, Hadjantonakis AK
(2010) A sensitive and bright single-cell resolution live imaging
reporter of Wnt/ss-catenin signaling in the mouse. BMC Dev Biol 10:
121
61. Valenta T, Gay M, Steiner S, Draganova K, Zemke M, Hoffmans R, Cinelli
P, Aguet M, Sommer L, Basler K (2011) Probing transcription-specific
outputs of beta-catenin in vivo. Genes Dev 25: 2631 – 2643
62. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A,
Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond:
promoter analysis based on transcription factor binding sites. Bioinfor-
matics 21: 2933 – 2942
63. Proffitt KD, Madan B, Ke Z, Pendharkar V, Ding L, Lee MA, Hannoush
RN, Virshup DM (2013) Pharmacological inhibition of the Wnt acyl-
transferase PORCN prevents growth of WNT-driven mammary cancer.
Cancer Res 73: 502 – 507
64. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R
(1995) Lack of beta-catenin affects mouse development at gastrulation.
Development 121: 3529 – 3537
65. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP,
Sommer L, Boussadia O, Kemler R (2001) Inactivation of the beta-
catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain
malformation and failure of craniofacial development. Development
128: 1253 – 1264
66. Perantoni AO, Timofeeva O, Naillat F, Richman C, Pajni-Underwood S,
Wilson C, Vainio S, Dove LF, Lewandoski M (2005) Inactivation of FGF8
in early mesoderm reveals an essential role in kidney development.
Development 132: 3859 – 3871
67. Dunty WC Jr, Biris KK, Chalamalasetty RB, Taketo MM, Lewandoski M,
Yamaguchi TP (2008) Wnt3a/beta-catenin signaling controls posterior
body development by coordinating mesoderm formation and segmen-
tation. Development 135: 85 – 94
68. Garriock RJ, Chalamalasetty RB, Kennedy MW, Canizales LC,
Lewandoski M, Yamaguchi TP (2015) Lineage tracing of neuromeso-
dermal progenitors reveals novel Wnt-dependent roles in trunk
progenitor cell maintenance and differentiation. Development 142:
1628 – 1638
69. Dunty WC Jr, Kennedy MW, Chalamalasetty RB, Campbell K, Yama-
guchi TP (2014) Transcriptional profiling of Wnt3a mutants identifies
Sp transcription factors as essential effectors of the Wnt/beta-
catenin pathway in neuromesodermal stem cells. PLoS One 9:
e87018
70. Kennedy MW, Chalamalasetty RB, Thomas S, Garriock RJ, Jailwala P,
Yamaguchi TP (2016) Sp5 and Sp8 recruit beta-catenin and Tcf1-Lef1
to select enhancers to activate Wnt target gene transcription. Proc Natl
Acad Sci USA 113: 3545 – 3550
71. Hensen SM, Heldens L, van Enckevort CM, van Genesen ST, Pruijn GJ,
Lubsen NH (2012) Heat shock factor 1 is inactivated by amino acid
deprivation. Cell Stress Chaperones 17: 743 – 755
72. Rosilio C, Nebout M, Imbert V, Griessinger E, Neffati Z, Benadiba
J, Hagenbeek T, Spits H, Reverso J, Ambrosetti D et al (2015)
L-type amino-acid transporter 1 (LAT1): a therapeutic target
supporting growth and survival of T-cell lymphoblastic
lymphoma/T-cell acute lymphoblastic leukemia. Leukemia 29:
1253 – 1266
73. Cormerais Y, Giuliano S, LeFloch R, Front B, Durivault J, Tambutte E,
Massard PA, de la Ballina LR, Endou H, Wempe MF et al (2016) Genetic
disruption of the multifunctional CD98/LAT1 complex demonstrates the
key role of essential amino acid transport in the control of mTORC1
and tumor growth. Cancer Res 76: 4481 – 4492
74. Carraro V, Maurin AC, Lambert-Langlais S, Averous J, Chaveroux C,
Parry L, Jousse C, Ord D, Ord T, Fafournoux P et al (2010) Amino acid
availability controls TRB3 transcription in liver through the GCN2/
eIF2alpha/ATF4 pathway. PLoS One 5: e15716
75. Upton JP, Wang L, Han D, Wang ES, Huskey NE, Lim L, Truitt M,
McManus MT, Ruggero D, Goga A et al (2012) IRE1alpha cleaves select
microRNAs during ER stress to derepress translation of proapoptotic
Caspase-2. Science 338: 818 – 822
76. Braun D, Wirth EK, Wohlgemuth F, Reix N, Klein MO, Gruters A,
Kohrle J, Schweizer U (2011) Aminoaciduria, but normal thyroid
hormone levels and signalling, in mice lacking the amino acid and
thyroid hormone transporter Slc7a8. Biochem J 439: 249 – 255
77. Broer A, Friedrich B, Wagner CA, Fillon S, Ganapathy V, Lang F, Broer S
(2001) Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2
requires different domains. Biochem J 355: 725 – 731
78. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K,
Matsuoka S, Noma A, Iwai K, Minato N (1999) 4F2 (CD98) heavy chain
is associated covalently with an amino acid transporter and controls
intracellular trafficking and membrane topology of 4F2 heterodimer. J
Biol Chem 274: 3009 – 3016
79. Fenczik CA, Zent R, Dellos M, Calderwood DA, Satriano J, Kelly C, Gins-
berg MH (2001) Distinct domains of CD98hc regulate integrins and
amino acid transport. J Biol Chem 276: 8746 – 8752
80. Chrostowski MK, McGonnigal BG, Stabila JP, Padbury JF (2009) LAT-1
expression in pre- and post-implantation embryos and placenta.
Placenta 30: 270 – 276
ª 2019 The Authors EMBO reports e48469 | 2019 19 of 20
Nadège Poncet et al EMBO reports
81. Ritchie JW, Taylor PM (2001) Role of the System L permease LAT1 in
amino acid and iodothyronine transport in placenta. Biochem J 356:
719 – 725
82. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, Saunders
T, Bonner-Weir S, Kaufman RJ (2001) Translational control is required
for the unfolded protein response and in vivo glucose homeostasis. Mol
Cell 7: 1165 – 1176
83. Dombroski BA, Nayak RR, Ewens KG, Ankener W, Cheung VG,
Spielman RS (2010) Gene expression and genetic variation in
response to endoplasmic reticulum stress in human cells. Am J Hum
Genet 86: 719 – 729
84. Krokowski D, Han J, Saikia M, Majumder M, Yuan CL, Guan BJ, Bevilac-
qua E, Bussolati O, Broer S, Arvan P et al (2013) A self-defeating
anabolic program leads to beta-cell apoptosis in endoplasmic reticu-
lum stress-induced diabetes via regulation of amino acid flux. J Biol
Chem 288: 17202 – 17213
85. Yoshida H, Haze K, Yanagi H, Yura T, Mori K (1998) Identification of the
cis-acting endoplasmic reticulum stress response element responsible
for transcriptional induction of mammalian glucose-regulated proteins.
Involvement of basic leucine zipper transcription factors. J Biol Chem
273: 33741 – 33749
86. Nakamura Y, de Paiva Alves E, Veenstra GJ, Hoppler S (2016) Tissue-
and stage-specific Wnt target gene expression is controlled subsequent
to beta-catenin recruitment to cis-regulatory modules. Development
143: 1914 – 1925
87. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA (2009)
Wnt/beta-catenin signaling is required for CNS, but not non-CNS,
angiogenesis. Proc Natl Acad Sci USA 106: 641 – 646
88. Rossol-Allison J, Stemmle LN, Swenson-Fields KI, Kelly P, Fields PE,
McCall SJ, Casey PJ, Fields TA (2009) Rho GTPase activity modulates
Wnt3a/beta-catenin signaling. Cell Signal 21: 1559 – 1568
89. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q,
Bennett C, Harada Y, Stankunas K et al (2006) TSC2 integrates Wnt
and energy signals via a coordinated phosphorylation by AMPK and
GSK3 to regulate cell growth. Cell 126: 955 – 968
90. Castilho RM, Squarize CH, Chodosh LA, Williams BO, Gutkind JS (2009)
mTOR mediates Wnt-induced epidermal stem cell exhaustion and
aging. Cell Stem Cell 5: 279 – 289
91. Chen J, Tu X, Esen E, Joeng KS, Lin C, Arbeit JM, Ruegg MA, Hall MN,
Ma L, Long F (2014) WNT7B promotes bone formation in part through
mTORC1. PLoS Genet 10: e1004145
92. Fishwick KJ, Li RA, Halley P, Deng P, Storey KG (2010) Initiation of
neuronal differentiation requires PI3-kinase/TOR signalling in the verte-
brate neural tube. Dev Biol 338: 215 – 225
93. Nie X, Zheng J, Ricupero CL, He L, Jiao K, Mao JJ (2018) mTOR acts as a
pivotal signaling hub for neural crest cells during craniofacial develop-
ment. PLoS Genet 14: e1007491
94. Sherwood V (2015) WNT signaling: an emerging mediator of cancer cell
metabolism? Mol Cell Biol 35: 2 – 10
95. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD,
Xavier R, Stappenbeck TS, Virgin HW (2010) Virus-plus-susceptibility
gene interaction determines Crohn’s disease gene Atg16L1 phenotypes
in intestine. Cell 141: 1135 – 1145
96. Greene ND, Copp AJ (2014) Neural tube defects. Annu Rev Neurosci 37:
221 – 242
97. Shi H, Enriquez A, Rapadas M, Martin E, Wang R, Moreau J, Lim CK,
Szot JO, Ip E, Hughes JN et al (2017) NAD deficiency, congenital malfor-
mations, and niacin supplementation. N Engl J Med 377: 544 – 552
98. Sparrow DB, Chapman G, Smith AJ, Mattar MZ, Major JA, O’Reilly VC,
Saga Y, Zackai EH, Dormans JP, Alman BA et al (2012) A mechanism for
gene-environment interaction in the etiology of congenital scoliosis.
Cell 149: 295 – 306
99. Moreau JLM, Kesteven S, Martin E, Lau KS, Yam MX, O’Reilly VC, Del
Monte-Nieto G, Baldini A, Feneley MP, Moon AM et al (2019) Gene-
environment interaction impacts on heart development and embryo
survival. Development 146: dev172957
100. Shi H, O’Reilly VC, Moreau JL, Bewes TR, Yam MX, Chapman BE, Grieve
SM, Stocker R, Graham RM, Chapman G et al (2016) Gestational stress
induces the unfolded protein response, resulting in heart defects.
Development 143: 2561 – 2572
101. Potter SW, Morris JE (1985) Development of mouse embryos in hanging
drop culture. Anat Rec 211: 48 – 56
102. Placzek M, Dale K (1999) Tissue recombinations in collagen gels. Meth-
ods Mol Biol 97: 293 – 304
103. McFarlane L, Truong V, Palmer JS, Wilhelm D (2013) Novel PCR assay
for determining the genetic sex of mice. Sex Dev 7: 207 – 211
104. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P,
Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq
aligner. Bioinformatics 29: 15 – 21
105. McCarthy DJ, Chen Y, Smyth GK (2012) Differential expression analysis
of multifactor RNA-Seq experiments with respect to biological varia-
tion. Nucleic Acids Res 40: 4288 – 4297
106. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor
package for differential expression analysis of digital gene expression
data. Bioinformatics 26: 139 – 140
107. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta C(T))
method. Methods 25: 402 – 408
108. Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon JA, van
der Lee R, Bessy A, Cheneby J, Kulkarni SR, Tan G et al (2018) JASPAR
2018: update of the open-access database of transcription factor bind-
ing profiles and its web framework. Nucleic Acids Res 46: D260 –D266
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
20 of 20 EMBO reports e48469 | 2019 ª 2019 The Authors
EMBO reports Nadège Poncet et al
